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Many studies have addressed the effect of dietary
glycemic index on obesity and diabetes, but little is
known about its effect on life span itself. We found
that adding a small amount of glucose to themedium
(2%) shortened the life span of C. elegans by inhibit-
ing the activities of life span-extending transcription
factors that are also inhibited by insulin signaling:
the FOXO family member DAF-16 and the heat shock
factor HSF-1. This effect involved the downregulation
of an aquaporin glycerol channel, aqp-1. We show
that changes in glycerol metabolism are likely to
underlie the life span-shortening effect of glucose
and that aqp-1 may act cell nonautonomously as a
feedback regulator in the insulin/IGF-1-signaling
pathway. Insulin downregulates similar glycerol
channels in mammals, suggesting that this glucose-
responsive pathway might be conserved evolution-
arily. Together, these findings raise the possibility
that a low-sugar diet might have beneficial effects
on life span in higher organisms.
INTRODUCTION
Diets of industrialized countries tend to have high glycemic index
(GI) values. The high-GI diets, which are enriched in processed
carbohydrates or sugars, are easily metabolized to glucose and
raise blood glucose level very quickly. High-GI diets have been
linked to obesity, type 2 diabetes, and cardiovascular diseases
(Aston, 2006; Venn and Green, 2007). How high-GI diets may
accelerate the onset and progression of these diseases is not
clear. Possible mechanisms include direct metabolic effects,
changes in body weight, and alterations in hormonal regulatory
systems. The hormone insulin may mediate at least some of the
effects of the high-GI diets on human health. Blood insulin levels
rise rapidly after the consumption of high-GI foods and then fall
quickly (Aston, 2006; Venn and Green, 2007). This dramatic fluc-
tuation in insulin levels may lead to insulin resistance and eventu-Cell Mally to type 2diabetes, although further research on themolecular
effects of insulin fluctuations is required.
The insulin-signaling pathway is evolutionarily well conserved
from C. elegans to mammals (Barbieri et al., 2003; Katic and
Kahn, 2005). In mammals, insulin and its close homolog IGF-1
bind to tyrosine-kinase receptors and result in the inhibition of
the FOXO transcription factor, an important transcriptional regu-
lator of many cellular processes such as metabolism, stress
responses, and apoptosis (Barbieri et al., 2003; Katic and
Kahn, 2005; Salih and Brunet, 2008).
The insulin/IGF-1-signaling pathway has been shown to regu-
late the life span of many organisms (Barbieri et al., 2003; Katic
and Kahn, 2005; Kenyon, 2005). Reducing the activity of this
pathway—for example, by mutation of the C. elegans daf-2
insulin/IGF-1 receptor gene (Kimura et al., 1997)—slows the
aging process and doubles life span (Kenyon et al., 1993). This
extended life span requires the activity of the FOXO transcription
factor DAF-16 and the heat shock transcription factor HSF-1
(Henderson and Johnson, 2001; Hsu et al., 2003; Kenyon
et al., 1993; Lee et al., 2001; Lin et al., 1997, 2001; Morley and
Morimoto, 2004; Ogg et al., 1997). In addition, DAF-16 and
HSF-1 contribute to the longevity of wild-type animals cultured
on bacteria under standard laboratory conditions, as reducing
either daf-16 or hsf-1 gene activity accelerates the rate of tissue
aging and shortens life span (Garigan et al., 2002; Herndon et al.,
2002; Kenyon et al., 1993; Lin et al., 2001). Although the connec-
tion between the insulin/IGF-1-signaling pathway and aging in
C. elegans has been well established, our current knowledge
of the effect of glucose on the C. elegans insulin/IGF-1-signaling
pathway and on life span is very limited.
In this study, we tested whether glucose feeding affected the
life span of C. elegans. As recently shown by Schulz et al. in an
independent study (Schulz et al., 2007), we found that a
glucose-enriched diet significantly shortened the life span of
C. elegans. We then found that glucose decreased life span
by inhibiting the DAF-16 and HSF-1 transcription factors. In
addition, we found that the downstream aquaporin gene aqp-1,
which encodes a glycerol channel, was responsible for the life
span-shortening effect of aglucose-containingdiet. Inmammals,
insulin represses the expression of genes encoding similar aqua-
porin glycerol channels (Kishida et al., 2001; Kuriyama et al.,etabolism 10, 379–391, November 4, 2009 ª2009 Elsevier Inc. 379
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mice causesobesity and insulin resistance, pointing to the impor-
tance of these glycerol channels in mammalian glucose metabo-
lism (Hara-Chikuma et al., 2005; Hibuse et al., 2005). The role of
glycerol channels in glucosemetabolism seems to be conserved
in C. elegans, since we found that C. elegans aqp-1 was also
a glucose-regulated downstream target of DAF-16 and HSF-1.
Furthermore, we showed that aqp-1, in turn, influenced DAF-16
activity. This positive feedback loop may act cell nonautono-
mously to adjust the level of DAF-16/FOXO activity among the
tissues. It is possible that, like many other pathways that affect
aging (Barbieri et al., 2003; Guarente, 2007; Katic and Kahn,
2005; Kenyon, 2005; Piper and Bartke, 2008; Stepanyan et al.,
2006), the glucose-responsive pathway might be conserved
from C. elegans to mammals. If so, then low-sugar diets might
have beneficial effects onmammalian aging. Surprisingly, dietary
glucose could completely suppress the long life span of daf-2()
insulin/IGF-1 receptor mutants in C. elegans, suggesting that
individualswith an impaired insulin receptormight benefit dispro-
portionately from a low-sugar diet.
RESULTS
Dietary Glucose Shortens the Life Span of C. elegans
To ask whether glucose might influence the life span of
C. elegans, which are normally fed a diet of E. coliOP50 bacteria,
we added 2% glucose to culture plates containing normal
growth (NG) medium and a lawn of bacteria. We found that
glucose addition decreased life span by approximately 20%
(Figure 1A). This life span shortening required glucose treatment
during adulthood, as feeding only during development had no
effect on adult life span (Figure 1B).
We confirmed that the animals ingested glucose, as glucose-
treated worms contained 50% more glucose than did control
animals (Figure 1C). To test whether an indirect effect of glucose
addition might influence life span, we asked whether increased
osmolarity or glucose-fed bacteria could shorten the life span
of C. elegans. Neither of these treatments appeared to have
any effect. First, 2% L-glucose or D-sorbitol did not affect life
span (Figures 1D and 1E), whereas as little as 0.1% (5.6 mM)
D-glucose was sufficient to decrease life span significantly
(Figure 1F). Second, when we cultured worms on NG medium
(no added glucose) plated with bacteria prefed 2% glucose,
the animals were not short lived (Figure 1G), arguing against
the possibility that a metabolite of glucose produced by the
bacteria was responsible for the shorter life span. Consistent
with this, animals were short lived when cultured on 2% glucose
plates containing killed bacteria (Figure 1G). Likewise, 2%
glucose plates seeded with DPTS mutant bacteria, which are
defective in glucose uptake (Deutscher et al., 2006), decreased
the life span of the animals (Figure 1H). Taken together, these
data suggest that glucose consumption directly decreases the
life span of C. elegans. However, we note that we cannot rule
out the possibility that the sensory perception of glucose plays
a role in this pathway. While this study was in progress, Schulz
et al. reported independently that glucose shortens C. elegans’
life span and described analogous control experiments (Schulz
et al., 2007).380 Cell Metabolism 10, 379–391, November 4, 2009 ª2009 ElsevieGlucose Shortens Life Span by Decreasing
DAF-16/FOXO and HSF-1 Activity
Because glucose stimulates insulin secretion in mammals, we
wondered whether glucose might shorten the life span of
C. elegans by influencing components of the insulin/IGF-1-sig-
naling pathway. Insulin/IGF-1 signaling inhibits the transcrip-
tional activity of DAF-16/FOXO (Salih and Brunet, 2008). When
insulin/IGF-1 signaling is reduced, life span is doubled, and
this life span extension requires daf-16 (Kenyon et al., 1993).
Conversely, when daf-16 is deleted in otherwise normal animals,
the rate of tissue aging is accelerated, and life span is shortened
by 20% (Garigan et al., 2002; Lin et al., 2001). We found that
glucose did not further shorten the life span of daf-16() animals
(Figures 2A and S4A).
The long life span produced by inhibiting insulin signaling in
C. elegans also requires the heat shock transcription factor
hsf-1 (Hsu et al., 2003; Morley and Morimoto, 2004), and as
with daf-16, reducing hsf-1 activity accelerates aging and
shortens life span (Garigan et al., 2002). We found that glucose
did not further shorten the life span of hsf-1() mutants (Figures
2B and S4B). The effect of glucose on daf-16() and hsf-1()
animals was specific, because glucose did shorten the life
span of animals containing mutations in many other genes that
affect life span, including sir-2.1(), aak-2(), nhr-49(), and
daf-12() (Figures S5 and S6, described below). In addition,
glucose treatment also completely suppressed the long life
span caused by hsf-1 overexpression, which is daf-16 depen-
dent (Hsu et al., 2003) (Figure 2C). This genetic specificity impli-
cates daf-16 and hsf-1 in the longevity response to dietary
glucose and suggests that glucose is not simply toxic to worms
in a general, nonspecific way.
During development, the insulin/IGF-1 pathway regulates
a hibernation-like state called dauer diapause (Hu, 2007). The
dauer is an alternative third larval stage that worms enter in
response to food limitation and crowding. Whereas animals
carrying weak daf-2 mutations become long-lived adults,
animals carrying stronger mutations become dauers constitu-
tively, as do animals carrying weak daf-2 mutations but grown
at high temperature (Hu, 2007). Like adult life span extension,
dauer formation requires daf-16. We found that 2% glucose
feeding reduced the fraction of the animals that became dauers
at 22.5C in strains carrying reduction-of-function mutations in
daf-2 (Figure 3A). This was true for two different reduction-
of-function alleles of daf-2, daf-2(e1368) and daf-2(e1370). In
addition, glucose feeding suppressed dauer formation in wild-
type animals grown at a higher temperature, 27C (Figure 3B).
These data are consistent with the hypothesis that glucose treat-
ment upregulates the insulin/IGF-1-signaling pathway, which
in turn counteracts the reduced activity of the insulin/IGF-1
receptor in these animals.
Many DAF-16-regulated genes have been identified in micro-
array and other studies (Halaschek-Wiener et al., 2005; Lee et al.,
2003; McElwee et al., 2003, 2004; Murphy et al., 2003; Oh et al.,
2006; Ookuma et al., 2003). To ask whether glucose affects the
expression of known DAF-16-regulated genes, we carried out
microarray analysis. We found that treating wild-type animals
with 2% glucose produced a pattern of gene expression that
overlapped significantly with that produced by genetic inhibition
of daf-16 activity in daf-2 insulin/IGF-1 receptor mutantsr Inc.
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Life Span Control by Glucose, FOXO, and AquaporinsFigure 1. Glucose Feeding Shortens the Adult Life Span of C. elegans
(A) A diet containing 2% D-glucose (glucose) decreased the life span of wild-type (N2) animals significantly.
(B) Glucose feeding initiated on day 1 of adulthood (Glc. from d1 adult) shortened the life span of wild-type animals, but glucose feeding during entire larval
developmental period (Glc. until d1 adult) did not.
(C) Glucose feeding increased the glucose level inside the animals. Error bars represent SEM (*p < 0.05, two-tailed Student’s t test).
(D and E) In contrast to D-glucose, diet containing 2% L-glucose (D) or sorbitol (E) did not shorten life span. See Table S1 for additional trials and statistical
analysis for these and all other life span data.
(F) 0.1% glucose was sufficient to affect life span. See Figure S2 for other glucose concentrations.
(G) Worms grown on glucose-containing plates (glc. plate) with dead bacteria were short lived whether the bacteria had been previously cultured with glucose
(glc./ glc. plate) or not (con./ glc. plate). In contrast, growing bacteria in 2% glucose media prior to killing the bacteria and moving to a control plate without
glucose (glc./ con. plate) was not sufficient to affect life span.
(H) Worms fed with glucose-uptake-defective DPTS OP50 double mutant bacteria (DPTS) (Figure S3) grown on 2% glucose plates were short lived. Finally, since
progeny number is negatively correlated with life span in many cases, we measured the effect of glucose feeding on total progeny number. However, glucose
feeding decreased the total progeny number (Figure S1).(hypergeometric probabilities, p < 1010) (Table 1). We also
observed changes in expression of several insulin-like genes,
including the known DAF-16 target gene ins-7 (Figure S7A),
which affects life span (Murphy et al., 2003; Murphy et al.,
2007). Consistent with this, we observed increased ins-7::GFP
expression in transgenic animals upon addition of glucose
(Figures S7B–S7D). In addition, we found that the DNA motifCell MCTTATCA (Budovskaya et al., 2008), which we previously
showed to be overrepresented in the upstream sequence of
the DAF-16-regulated genes (Murphy et al., 2003), was signifi-
cantly overrepresented in the promoter regions (2 kb) of the
glucose-responsive genes, as well (p < 105) (Table 1). This
sequence was shown recently to bind to DAF-16 (Curran et al.,
2009). These findings support the hypothesis that glucoseetabolism 10, 379–391, November 4, 2009 ª2009 Elsevier Inc. 381
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Life Span Control by Glucose, FOXO, and AquaporinsFigure 2. The Life Span-Shortening Effect of Glucose Requires the DAF-16 and HSF-1 Transcription Factors
(A and B) The short life span of the null allele daf-16(mu86) (A) (daf-16(); in this and other figures, () refers to a reduction or loss-of-function mutation, and the
specific allele is given in the corresponding figure legend) or hsf-1(sy441, RNAi) (B) animals was not further decreased by glucose feeding. In contrast, wild-type
animals (WT) lived significantly shorter on a diet containing 2% glucose.
(C) The long life span caused by overexpression of hsf-1 (hsf-1 OE) was suppressed by adding 2% glucose to the diet. See Figures S3–S5 for the life span data
of additional mutants we tested: daf-16(RNAi), hsf-1(sy441), sir-2.1(ok434), aak-2(ok524), aak-1(RNAi), aak-1(RNAi); aak-2(ok524), nhr-49(gk405), and
daf-12(rh61rh411) animals. Note: The aak-2 mutations affect subunits of AMP kinase, and nhr-49 and daf-12 encode nuclear hormone receptors.shortens life span by preventing DAF-16 from regulating the
expression of specific target genes.
Glucose Completely Prevented daf-2 Mutations
from Extending Life Span
Because the activity of the insulin/IGF-1 pathway is required for
growth to adulthood (Hu, 2007), the daf-2mutations that extend382 Cell Metabolism 10, 379–391, November 4, 2009 ª2009 Elsevierlife span only partially inhibit gene activity. Thus, it was hard
to predict what effect glucose might have on the life spans of
daf-2 mutants. We found that glucose almost completely sup-
pressed the life span extension of daf-2(e1368) (ligand-binding
domain) and daf-2(e1370) (tyrosine kinase) mutants (Kimura
et al., 1997) back to wild-type levels (Figures 3C and 3D). This
dramatic effect, which was seen in multiple trials, suggestsFigure 3. Glucose May Influence Insulin/IGF-1 Signaling to Regulate Dauer Formation and Life Span
(A and B) Glucose feeding significantly decreased dauer formation caused by daf-2(e1370) or daf-2(e1368)mutation at 22.5C (A) or by growth at 27C (B). Error
bars are SEM (***p < 0.001, **p < 0.01, two-tailed Student’s t test).
(C and D) The extreme longevity caused by some daf-2/insulin-IGF-1 receptor mutations was completely suppressed by glucose feeding. Glucose feeding
suppressed the longevity caused by daf-2(e1368) (C) and daf-2(e1370) (D) mutations.Inc.
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Life Span Control by Glucose, FOXO, and Aquaporinsthat glucose can suppress the life span-extending effect of even
very high levels of DAF-16 activity. This finding suggested that
glucose would also suppress the extended life span of ins-
7(RNAi) animals, and we found that this was the case
(Figure S7E).
Glucose May Shorten Life Span by Altering
aqp-1 Expression
To better understand how glucose affects life span, we tested
the functions of genes whose expression changed in response
to glucose. To do this, we outcrossed available mutants to our
wild-type (N2) strain and measured life span (Figures 4A and
S10). Of sevenmutants that we tested, one, an aqp-1() deletion
mutant, behaved remarkably likedaf-16() andhsf-1()mutants:
aqp-1mutants were short-lived, and their short life span was not
further decreased by glucose (Figure 4A). This finding suggested
that glucose shortens life span by downregulating the expression
of aqp-1. Consistent with this interpretation, we found that over-
expression of a functional aqp-1::GFP fusion (Huang et al., 2007),
which rescued the short life span of the aqp-1 deletion mutant
(Figure 4B), partially prevented glucose from shortening life
span (Figure 4C). This observation is significant because it argues
that reduction of aqp-1 activity is required for glucose to shorten
life span. Together, these findings suggest that glucose shortens
life span by inhibiting aqp-1 activity.
Because of the similarities among the life span phenotypes of
daf-16, hsf-1, and aqp-1 mutants, we hypothesized that aqp-1
is a particularly important transcriptional target of both DAF-16
and HSF-1 in animals fed glucose. We performed quantitative
RT-PCR to compare the levels of aqp-1 transcripts in wild-type,
daf-16(), hsf-1(), and daf-16() hsf-1() animals with and
without glucose. We found that glucose feeding downregulated
aqp-1 in wild-type animals, consistent with our microarray data
(Figure 4D and Table 1). In addition, aqp-1 was repressed in
daf-16(), hsf-1(), and daf-16() hsf-1() animals compared
towild-type, suggesting that normal expression of aqp-1 requires
these transcription factors (Figure 4D). In contrast to the effects of
dietary glucose on wild-type animals, glucose feeding did not
significantly affect aqp-1expression in thesemutants (Figure 4D).
In addition, we found that aqp-1() mutation did not further
decrease the short life span caused by daf-16(), hsf-1(), or
daf-16() hsf-1()mutations (Figures 4E, 4F, andS11). Together,
these data strongly suggest that glucose, aqp-1, hsf-1, and daf-
16all act in the samepathway, inwhichglucoseshortens life span
by downregulating the activities of DAF-16 and HSF-1, which in
turn downregulates aqp-1 expression.
Glycerol May Play an Important Role
in Life Span Shortening
aqp-1 encodes a glycerol channel (Huang et al., 2007), which is
noteworthy because mammalian glycerol channels have been
implicated in glucose homeostasis (Hara-Chikuma and Verk-
man, 2006). Because the AQP-1 channel may alter glycerol
metabolism, we wondered what effect glycerol itself might
have on life span. To investigate this, we measured the life
span of animals grown on normal culture plates supplemented
with 1% glycerol (a molarity equivalent to 2% glucose) and a
lawn of E. coli bacteria. We found that glycerol feeding
decreased the life span of wild-type animals by 23%–36% (Fig-Cell Mure 5A), which was similar to the effect of glucose feeding. We
then tested whether glycerol treatment affected the life span of
daf-16(), hsf-1(), or aqp-1() mutants. Similar to glucose
treatment, we found that adding glycerol to the diet of these
mutants had little or no effect on their already short life span
(Figures 5B–5D). In addition, we found that glycerol feeding
repressed aqp-1 expression (Figure 5E).
The similarity between the effects of glucose and glycerol on
the life span of wild-type, daf-16(), hsf-1(), and aqp-1()
animals suggested that glucose and glycerol may act in the
same way (or in the same pathway) to shorten life span. One
possibility was that glucose and glycerol have similar effects
on life span because they are metabolically interchangeable in
C. elegans. We examined this possibility by measuring glucose
and glycerol in the glucose-fed or glycerol-fed animals. We
found that glucose feeding increased both glucose and glycerol
in the animals (Figures S12A and S12B). However, glycerol-fed
animals contained increased levels of glycerol but not glucose
(Figures 5F and 5G). These data suggest that dietary glucose
is metabolized to glycerol and that this glycerol may in turn
decrease the life span of the animal.
AQP-1 Is a Feedback Regulator of Insulin/IGF-1
Signaling
The aqp-1 transgene is expressed in the pharynx and intestine
(which behaves as the entire endoderm of the animal, including
its adipose tissue) (Huang et al., 2007). We examined levels of
glucose and glycerol in aqp-1 mutants with or without dietary
glucose, but we did not find any significant difference between
whole wild-type versus aqp-1() animals (Figures S12A and
S12B). Thus, presumably, aqp-1 influences the distribution of
glycerol within the animal (something that we cannot measure
with current technology).
The fact that loss of aqp-1 caused a life span phenotype that
was similar to that caused by loss of daf-16 itself was striking
and stimulated us to test the possibility that AQP-1 might be
acting in a regulatory pathway. Specifically, we hypothesized
that AQP-1 action might affect the transcription of DAF-16-
and/or HSF-1-regulated genes. To test this hypothesis, we
measured mRNA levels of 80 DAF-16 and/or HSF-1 target genes
using quantitative RT-PCR analysis. We found that a significant
fraction of the genes that are downregulated by mutations in
daf-16 and/or hsf-1 (8 out of 44) were also significantly downre-
gulated by the aqp-1mutation (Figures 6A and S13). One daf-16
and hsf-1 target (out of 36 tested) was upregulated by the aqp-1
mutation (Figures 6B and S14). This was the insulin-like peptide
ins-7, which was also regulated by glucose, as mentioned
above, and is known to influence life span (Murphy et al., 2003,
2007).
The finding that aqp-1 regulates ins-7 suggested that aqp-1
might influence DAF-16 target gene expression in a cell-nonau-
tonomous fashion. To test this idea, we crossed the aqp-1muta-
tion into a strain carrying aGFP reporter fusion to the promoter of
a direct DAF-16 target gene, sod-3 (Honda and Honda, 1999).
Interestingly, we found that the level of sod-3::GFP in the head
muscle was decreased by aqp-1 mutation or glucose feeding
(Figures 6C–6F). Based on the transgene experiments (Huang
et al., 2007) aqp-1 seems to be expressed only in the intestine
and pharynx and not in the muscle, although it remains possibleetabolism 10, 379–391, November 4, 2009 ª2009 Elsevier Inc. 383
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Life Span Control by Glucose, FOXO, and AquaporinsTable 1. Genes Differentially Regulated by Glucose Treatment
Genes upregulated by glucose treatment
Transcript/Gene Brief description DAF-16 binding sitesa (bp) GTAAAC/TA
DAF-16 and GATA transcription
factor binding site (bp) CTTATCA
K09H11.7 Haloacid dehalogenase-like hydrolase 4863
C53A3.2b Haloacid dehalogenase-like hydrolase 4908, 4873, 4189 4550, 1559
C18H9.6 Unknown 4875 430
F44E7.2 Haloacid dehalogenase-like hydrolase 2485, 1801, 1766 2124, 636
K02G10.7 (aqp-8)c Major intrinsic protein (MIP), aquaporin 2919, 2080 230
Y40B10A.6 O-methyltransferase domain 2021, 390
F21C10.9 Unknown 2937, 1952, 1637, 373
K11D12.4 Choline or carnitine O-acyltransferase 3785, 826, 380 4348, 2735
F21F8.4b Putative aspartyl (acid) protease 3035 4371, 4035, 3162, 2287,
1531, 1484
C17C3.1d Lipid storage 4547, 2753,2033
Y69A2AR.4 (smf-3)c Solute carrier family 11 3187, 207, 194
F10D2.11 UDP-glucoronosyl/glucosyl transferase 843, 366 4076, 3374, 2136, 12
Y53F4B.6 Growth, size, and locomotor behavior
Y40B10A.2 O-methyltransferase domain 2335 1378
F15H10.1 (col-12) Collagen 4123, 3192, 1405 3147
C29E6.5 (nhr-43)c Nuclear hormone receptor 4528, 3392 1002, 943, 231
F31F4.5 Pseudogene
F09F3.9 Choline or carnitine O-acyltransferase 1395, 967, 42 988
Y80D3A.7 (ptr-22) Patched superfamily 4270, 2815 3331
F44G3.2 Plant ATP-guanido phosphotransferase 2651, 1490 4345
F15B9.1 (far-3) Fatty acid- and retinol-binding protein 3 1712, 421, 409 4749, 979
C54D10.1 (cdr-2)c Cadmium-responsive gene 2 4690, 2245, 2095, 2038, 1540, 1024
C05E11.4 (amt-1)b Ammonium transporter family 4905, 3889, 3671, 3440, 3246,
2591, 1606, 1327, 1240, 1118
1789, 1461
Genes downregulated by glucose treatment
Transcript/Gene Brief description DAF-16 binding sitesa (bp) GTAAAC/TA
DAF-16 and GATA transcription
factor binding site (bp) CTTATCA
ZK6.7ab Lipid storage, chromosome
segregation, pathogen response
2695, 859 4312, 3979, 80
C14C6.5 ShTK and CC domains
C50F7.5 Unknown 3658, 135 1107, 1084,240, 209
T20B12.4 Unknown
F48D6.4ab Unknown 4869, 4476, 4316, 1427 3835, 403
F32A5.5bb (aqp-1)c Aquaporin 172 2364, 2285, 112
F48D6.4cb Unknown 4869, 4476, 4316, 1427 3835, 403
ZK6.7bb Lipid storage, chromosome
segregation, pathogen response
2695, 859 4312, 3979, 80
Y4C6B.6b Glucosyl-ceramidases 3890, 3363, 2443, 1909 155, 70
F48D6.4bb Unknown 4869, 4476, 4316, 1427 3835, 403
F15E11.14b Unknown 2707 394
F27C8.4b Downstream target of a VHL-1 pathway 4923, 2524, 992 2810, 1883, 1007, 75
Y37A1B.12 (tor-1) May bind ATP 113, 59 4039
T08A9.9 Similar to bactericidal amoebapores 4817, 3857, 348 1039, 132
F59B2.11 Unknown 4056
C25B8.3a (cpr-6)c Cysteine protease domain 4500, 2119 1972
C23H5.8ac Unknown 4036 72
See Figure S8 for fold changes of these genes and Table S3 for fold changes of all the genes in microarray analysis.384 Cell Metabolism 10, 379–391, November 4, 2009 ª2009 Elsevier Inc.
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Life Span Control by Glucose, FOXO, and AquaporinsFigure 4. Downregulation of aqp-1, a Glucose-Responsive DAF-16/HSF-1 Target Gene, Is Responsible for the Effect of Glucose on Life Span
(A) The short life span caused by aqp-1() (aqp-1(tm339)) mutation was not further shortened by a diet containing 2% glucose, whereas the life span of wild-type
animals (WT) was shortened by a 2% glucose diet.
(B) A transgene expressing aqp-1::GFP completely rescued the short life span of aqp-1() animals.
(C) aqp-1::GFP transgenic animals were partially resistant to the life span-shortening effect of glucose diet, indicating that reduction of aqp-1 levels is required for
glucose to shorten life span.
(D) Glucose feeding or mutation of daf-16 or hsf-1 lowered aqp-1 mRNA levels. Panel shows quantitative RT-PCR analysis of aqp-1 mRNA level in wild-type,
daf-16() (daf-16(mu86)), hsf-1() (hsf-1(sy441, RNAi)), or daf-16() hsf-1() animals with (orange) or without (gray) glucose treatment. Error bars represent
SEM (***p < 0.001, **p < 0.01, two-way ANOVA followed by post hoc Bonferroni tests).
(E and F) In contrast to its life span-decreasing effect in wild-type animals, the aqp-1() mutation did not affect the short life span of daf-16() (E) or hsf-1()
(F) animals.that the aqp-1 transgene does not exactly reproduce the expres-
sion pattern of endogenous aqp-1. Thus, these data imply that
aqp-1 mutation affects the transcriptional activity of DAF-16 in
other tissues in a nonautonomous manner.
In otherwise wild-type animals, increasing DAF-16/FOXO
levels in the intestine increases DAF-16/FOXO activity in other
tissues in a process that appears to involve feedback regulation
of ins-7 (Libina et al., 2003; Murphy et al., 2007). Since aqp-1
mutations increased ins-7 expression, we wondered whetherCell Mthe aqp-1 mutation would also influence this FOXO-to-FOXO
signaling among tissues. To test this idea, we increased the level
of DAF-16 in the intestine of otherwise wild-type animals using
an intestine-specific daf-16 transgene (Pges-1::GFP::daf-16)
(Libina et al., 2003) and assayed the level of sod-3::GFP in other
tissues. In previous experiments, we showed that intestinal DAF-
16 overexpression leads to a dramatic increase in head-muscle
sod-3::GFP expression (Libina et al., 2003), as long as the head
muscles are daf-16(+). We found that in the presence of glucose,aWefound that37of the40glucose-responsive transcripts (93%)containoneormoreDAF-16bindingelements in their 5kbupstreamregulatory regions. This
enrichment is statistically significant (p < 0.05, hypergeometric probability) compared to that (78%) of randomC. elegansgenes (Kenyon andMurphy, 2006).
bGenes that were upregulated (or downregulated) both by glucose treatment and by inactivation of daf-16.
c The change in mRNA expression level upon glucose treatment was confirmed by qRT-PCR (Figure S9). The life span of deletion mutants for these
genes was measured (Figures 4A and S10).etabolism 10, 379–391, November 4, 2009 ª2009 Elsevier Inc. 385
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Life Span Control by Glucose, FOXO, and AquaporinsFigure 5. The Glycerol Channel AQP-1 Mediates the Life Span-Shortening Effect of Glycerol Feeding
(A) Diet containing 1% glycerol (glycerol) decreased the life span of wild-type animals significantly.
(B–D) The short life span of daf-16(mu86) (B), hsf-1(sy441) (C), or aqp-1(tm339) (D) animals was not further decreased by glycerol feeding. The life span of
hsf-1(sy441) mutants was decreased by glycerol feeding in one out of two trials (Table S1). However, the % decrease in life span (11%) caused by glycerol
feeding was much smaller than that of wild-type animals (36%) in that trial.
(E) Glycerol feeding (Glycerol) significantly decreased the mRNA level of aqp-1.
(F and G) Glycerol treatment (Glycerol) increased the glycerol level inside the animals (F) but not the glucose level (G). Error bars represent SEM (*p < 0.05,
**p < 0.005, two-tailed Student’s t test). In an effort to confirm the effect of glycerol on life span using genetic models, wemeasured the life span of mutant animals
that have abnormal glycerol levels, but the data were inconclusive at this point. See Figure S17 and the figure legend for detail.the aqp-1 mutation reduced this upregulation of sod-3::GFP
expression in headmuscles (Figure 6G). Together, these findings
also imply a cell-nonautonomous role for aqp-1 in the homeo-
stasis of this hormonal signaling system.
DISCUSSION
Glucose Decreases Life Span by Inhibiting
DAF-16 and HSF-1
A major finding of this study is that glucose is a potent life
span-shortening agent inC. elegans that appears to act bydown-
regulating the activities of the life span-extending proteins DAF-
16/FOXOandHSF-1.Several linesofevidence lead to thisconclu-
sion. First, glucose shortened the life span of wild-type animals,
but it did not further decrease the life span of the already short-
lived daf-16() or hsf-1() mutants. Second, like daf-16() or386 Cell Metabolism 10, 379–391, November 4, 2009 ª2009 Elseviehsf-1() mutations, glucose feeding could suppress the long life
span of daf-2/insulin/IGF-1 receptor mutants and that of animals
overexpressinghsf-1. Third, glucose treatment suppresseddauer
formation, which is an alternative developmental stage that
requires DAF-16 activity. Finally, glucose feeding generated
a pattern of gene expression that overlapped significantly with
that produced by daf-16() mutations. Since both DAF-16 and
HSF-1 act downstream of and are inhibited by insulin/IGF-1
signaling inC. elegans, we propose that glucosemay act by stim-
ulating insulin/IGF-1 signaling. Consistent with this hypothesis,
glucose stimulates the expression of several insulin genes.
Glucose Dramatically Shortens the Long Life
Span of daf-2 Mutants
We were surprised to find that the long life spans of animals
carrying certain reduction-of-function mutations in the daf-2r Inc.
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Figure 6. The AQP-1/Glycerol Channel Acts as a Feedback Regulator in the Insulin/IGF-1-Signaling Pathway
(A) aqp-1 mutation significantly decreased the mRNA level of a direct DAF-16 target gene, sod-3.
(B) Expression of the insulin-like peptide gene ins-7 was induced by aqp-1 mutation. Error bars represent SEM (*p < 0.05, two-tailed Student’s t test). These
changes in sod-3 and ins-7 expression by aqp-1 mutation were not additive to daf-16() or hsf-1() mutations (Figure S16).
(C) aqp-1 mutant animals that express sod-3::GFP generally contain GFP in the pharynx but not in the surrounding head muscles.
(D and E) Some animals that express sod-3::GFP in a wild-type or in a Pges-1::GFP::daf-16 transgenic animal background contain GFP throughout the head and
often contain higher levels of GFP in the pharynx and intestine, as well. The upper edge of the animal’s head is indicated by the dashed yellow line. Arrowheads
indicate head muscles.
(F andG) Quantification of head-muscle sod-3::GFP expression for panels (D) and (E) without (F) or with (G)Pges-1::GFP::daf-16 (Pges-1::daf-16) (n : 75, *p < 0.05,
***p < 0.001, c2 test (Tullet et al., 2008).insulin/IGF-1 receptor gene were drastically reduced by glucose
feeding. It is possible that glucose suppresses the high level of
DAF-16 activity in these mutants by the same mechanism that it
uses to suppress normal DAF-16 activity in the wild-type animals.
However, in daf-2() mutants, loss of aqp-1 has a much more
modest (20%) effect on life span than does the addition of
glucose (Murphy et al., 2003). The physiology of daf-2 mutants
differs from that of wild-type in many ways, and some aspects of
this altered physiology must allow glucose to shorten life span
independently of aqp-1. The mechanism likely involves daf-16
downregulation, as glucose did not further shorten the life span
of daf-16(); daf-2() double mutants (Figure S19). The ability of
glucosetosuppress the lifespanextensionsof thesedaf-2mutants
is thought provoking, because it raises the possibility that themoreCell Mmodest (15%–30%)effects that inhibitionof insulin/IGF-1signaling
has on the life spanofmammals (Russell andKahn, 2007)might be
increased substantially by reducing the glycemic indices of their
diets.
Glucose Does Not Appear to Shorten Life Span
by Decreasing Respiration
In their recent study, Schulz et al. found that glucose decreases
oxygen consumption inwild-typeC. elegans (Schulz et al., 2007),
and we confirmed this finding in our laboratory (Figure S12C).
However, we did not find a significant difference between the
rates of oxygen consumption in aqp-1() animals and wild-
type (Figure S12C). Because the downregulation of aqp-1
appears to be necessary and at least partially sufficient foretabolism 10, 379–391, November 4, 2009 ª2009 Elsevier Inc. 387
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idea that glucose shortens life span by inhibiting respiration.
In addition, Schulz et al. proposed a model suggesting that
glucose may shorten life span by inactivating the AMP-depen-
dent kinase (AMPK) (Schulz et al., 2007). This model was mainly
based on their findings that the AMPK subunit AAK-2 is inacti-
vated by glucose treatment and that 2-deoxy-glucose (DOG),
which acts oppositely to glucose and increases life span, does
not lengthen the life span of aak-2 null mutants (Schulz et al.,
2007). This model predicts that glucose would not further
decrease the life span of aak-2 null mutants. However, we found
that glucose feeding did further decrease the short life span
caused by loss of aak-2, to the same extent as wild-type (Fig-
ure S5). Thus, our data imply that glucose does not shorten life
span by inactivating AMPK. Taken together, these findings argue
that whereas DOGmay extend life span by activating AMPK and
increasing respiration, the effect of glucose on life span is medi-
ated by another pathway.
Interestingly, Schulz et al. also proposed that DOG extends life
span by increasing the level of reactive oxygen species (ROS)
(Schulz et al., 2007). However, Schlotterer et al. recently showed
that short-lived, glucose-treated worms also display increased
ROS (Schlotterer et al., 2009). How this apparent paradox can
be resolved is not yet clear.
Similar Effects of Glucose and Glycerol on Life Span
We found that glucose and glycerol have very similar effects
on life span. Both glucose and glycerol significantly decreased
the life span of wild-type animals but did not further shorten
the life span of daf-16(), hsf-1(), or aqp-1() mutants. This
was unexpected. When present as the sole carbon source,
glucose and glycerol have opposite effects on intermediary
metabolism in yeast (Brisson et al., 2001). For example, growth
on glucose triggers catabolite repression, stimulates glycolysis,
and inhibits respiration, whereas growth on glycerol disinhibits
catabolite repression and stimulates respiration via the conver-
sion of glycerol to pyruvate. Thus, glycerol might have been
expected to lengthen, not shorten, the life span of C. elegans.
To what extent the pathways of carbohydrate metabolism differ
between worms and yeast is not known. However, we found that
worms fed glucose contain elevated levels of glycerol but not
vice versa, suggesting that glycerol may be an important inter-
mediate in the pathway through which glucose shortens life
span.
Onemetabolite whose level could be elevated by glucose and/
or glycerol feeding is fat, especially because glycerol is an essen-
tial building block of triglyceride. Consistent with this idea,
Schulz et al. showed that glucose feeding increases the level
of triglyceride in C. elegans (Schulz et al., 2007). These results
raise the possibility that the increased fat in the glucose-fed
animals could shorten life span directly. However, increased
fat alone is not sufficient to shorten life span, as some mutants
that contain high levels of fat, such as daf-2 mutants, live long
(Kimura et al., 1997). Moreover, since we found that downregu-
lation of the DAF-16/FOXO transcription factor, a condition
that does not elevate fat levels (Kimura et al., 1997), mediates
the life span-shortening effect of glucose feeding, it seems
unlikely that the increased fat level is responsible for the short-
ened life span caused by glucose feeding.388 Cell Metabolism 10, 379–391, November 4, 2009 ª2009 ElsevieThe fact that we identified a glycerol channel as a mediator for
the effect of glucose on life span further lends support to the idea
that glycerol plays an important role in the glucose metabolic
pathway. We speculate that glucose feeding may increase
glycerol level in C. elegans, which may downregulate the AQP-1
glycerol channel, and that this in turnmay lead to further changes
in glycerol metabolism and to short life span. Future studies
using traceable glycerol, which does not exist at present, are
required to test this model.
The AQP-1 Channel Appears to Act Cell
Nonautonomously
In daf-2mutants, DAF-16 appears to influence life span by regu-
lating multiple antioxidant, chaperone, immunity, metabolic, and
other genes that act in a cumulative way to influence life span
(Murphy et al., 2003). Thus, we were surprised to find that loss
of a single metabolic gene, aqp-1, could apparently account for
theeffectofglucoseon life span (at least inadaf-2(+)background).
Our finding that aqp-1acts as a regulatory gene that is required for
the expression of diverse DAF-16-regulated genes provides
apossible explanation for this finding.Bychanging the expression
of a variety of genes that individually have smaller effects on life
span, loss of aqp-1 could have a relatively large impact.
The mechanism by which this glycerol channel influences
DAF-16 target gene expression is not known, but our findings
indicate that AQP-1, which is present only in the intestine and
pharynx (Huang et al., 2007), is required for normal sod-3 expres-
sion in the head muscles. Thus, aqp-1 can function cell nonau-
tonomously. The finding that aqp-1 activity regulates ins-7, which
is expressed in the intestine and known to affect life span
(Murphy et al., 2003, 2007), suggests a model in which aqp-1
mutations change the level of glycerol in the intestine, which in
turn somehow affects the expression of ins-7 in that tissue. In
addition, since AQP-1 is a glycerol channel, it is also possible
that glycerol itself is an intercellular signal that can act on other
tissues to influence the expression of DAF-16 target genes.
Roles of Mammalian Glycerol Channels
in Glucose Metabolism
In mammals, AQPs 3, 7, 9, and 10 encode glycerol channels
(reviewed in Maeda et al., 2008). Among them, AQP7 and
AQP9 have interesting features that seem related to those of
C. elegans aqp-1. First, AQP7 and AQP9 are predominantly ex-
pressed in adipocytes and hepatocytes, respectively (Maeda
et al., 2008). In worms, aqp-1 is expressed in the intestine, which
performs at least some functions of these two tissues (fat storage
and yolk production). (C. elegans has no distinct adipose tissue
or liver.) The mRNA levels of AQP7 and AQP9 decrease upon
insulin secretion (Kishida et al., 2001; Kuriyama et al., 2002).
Moreover, both of these proteins influence insulin-dependent
physiology: AQP7 knockout mice exhibit insulin resistance and
obesity (Hibuse et al., 2005), whereas AQP9 deletion decreases
blood glucose levels in mice that are obese and diabetic (Rojek
et al., 2007). Fourth, recent human studies showed that AQP7
gene expression was significantly reduced in obese women
(Ceperuelo-Mallafre´ et al., 2007) and that AQP7 polymorphisms
were associatedwith risk of obesity anddiabetes (Prudente et al.,
2007). Together, these studies suggest that mammalian aqua-
porin/glycerol channels have important roles in glucoser Inc.
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channel is a glucose-responsive gene regulated by the insulin/
IGF-1 pathway and that it is crucial for mediating the effect of
glucose on life span. These findings suggest that C. elegans aqp-
1may be a functional homolog ofmammalian AQP7 and/or AQP9.
Potential Benefits of Diets with a Low GI
on Human Aging
The typical American diet contains high levels of sugar. A typical
candy bar contains 75% sugar, and the National Academy of
Sciences Dietary Reference Intake recommends limiting the
level of added sugar to 25% of total calories. Although we do
not fully understand the mechanism by which glucose shortens
the life span of C. elegans, the fact that the two mammalian
aquaporin glycerol-transporting channels are downregulated
by insulin raises the possibility that glucose may have a life
span-shortening effect in humans and, conversely, that a diet
with a low glycemic index may extend human life span. The
finding that FOXO3A variants have now been associated with
exceptional longevity in at least seven human cohorts (Willcox
et al., 2008; Flachsbart et al., 2009; Anselmi et al., 2009; Pawli-
kowska et al., 2009; Li et al., 2009) makes this possibility seem
realistic. It is particularly interesting to think about low-GI diets
in the context of our findings with the C. elegans insulin/IGF-1
receptor/daf-2 mutants. These animals, which are predicted to
be somewhat insulin resistant, have very long life spans in the
absence of glucose, but not in its presence. In multiple studies,
lowering the dietary GI has been shown to benefit humans with
insulin resistance associated with the metabolic syndrome or
type 2 diabetes (Aston, 2006; Venn and Green, 2007). Our find-
ings raise the unorthodox but nevertheless conceivable possi-
bility that humans with partially defective insulin receptors on
low-GI diets may be even more healthy and long-lived than
normal people on low-GI diets. Finally, because theyblockgluco-
neogenesis, drugs that inhibit glycerol aquaporin channels are
now under development pharmaceutically for the treatment of
diabetes (Fru¨hbeck et al., 2006). Our findings suggest that while
these drugs might be beneficial for curtailing glucose production
in diabetics, they may have additional, less beneficial effects.
EXPERIMENTAL PROCEDURES
Strains
See Table S6 for strains that were analyzed in this study.
Life Span Analysis
All life span measurements were performed at 20C, as described previously
(Apfeld and Kenyon, 1999), starting with day 1 adults. In some experiments,
D-glucose, L-glucose, D-sorbitol, or glycerol was added to standard NG
agar plates. The chemical 5-fluoro-20-deoxyuridine (FUDR) (75 mM, Sigma;
St. Louis) was added to prefertile young adult animals to prevent their progeny
from developing unless stated otherwise. For the RNAi experiments, eggs
were added to plates seeded with bacteria expressing double-strand RNA
of given genes.
Progeny Profiles
Single L4 stage wild-type (N2) worms grown on OP50 bacteria with or without
2%glucosewere placed on individual plates at 20C (36 worms per condition).
The animals were then transferred to new plates every 24 hr for 7 days while
they produced progeny. Bagged or ruptured worms were censored. All the
plates containing progeny were incubated for 2–3 days after removing the
parental worms, and the number of worms that developed was counted.Cell MDauer Assay
Animals were grown at 22.5C or 27C as indicated. After 3 days of incubation,
dauers were scored under a dissecting microscope.
Microarray Analysis
Synchronized day 1 adult animals that were cultured at 20C were harvested,
washed three times in M9, and frozen immediately using liquid nitrogen. Total
RNA extraction, mRNA purification, reverse transcription of mRNA, labeling,
and hybridization were performed as described previously (Murphy et al.,
2003). Six biological replicate samples of glucose-fed versus control wild-
type adult animals were used to identify the glucose-responsive genes (GEO
Accession GSE 18562) (Tables 1 and S3). Four biological replicate samples
of daf-2(e1370) versus daf-16(RNAi); daf-2(e1370) and four biological replicate
samples of fer-15(b26); daf-2(mu150); fem-1(hc17) versus daf-16(RNAi); fer-
15(b26); daf-2(mu150); fem-1(hc17) animals were used for identification of
genes that are regulated by DAF-16 in daf-2 mutants (GEO Accession GSE
18561) (Tables S2 and S4).
Microarray raw data were normalized using Acuity 4.0 (Molecular Devices;
Sunnyvale, CA). Significance Analysis of Microarray (SAM) (Tusher et al.,
2001) was performed to identify genes that were differentially regulated in
each of the comparisons. For glucose-responsive genes, 5% median false-
positive discovery rate was used (Table 1). For DAF-16 regulated genes, 1%
median false-positive discovery rate was used (Table S2).
DAF-16-regulated genes in daf-2() mutants were compared with previ-
ously published data (McElwee et al., 2003; Murphy et al., 2003). The overlap
between DAF-16 target genes in this study and the genes from the previous
reports (McElwee et al., 2003; Murphy et al., 2003) was highly significant in
both comparisons (Figure S18).
Upstream Sequence Analysis
Upstream sequences for the glucose-responsive genes were extracted from
WormBase (http://www.wormbase.org). Regulatory Sequence Analysis Tools
(RSAT) (http://rsat.ulb.ac.be/rsat/) was used to search the sequence 2 kb
upstream of the translation start site of each open reading frame for overrepre-
sented sequences. DAF-16 andGATA transcription factor binding sites in the 5
kbupstreamof glucose-responsivegeneswere identified usingRSAT (Table 1).
Generation of DPTS OP50 Double Mutant E. coli
A DPTS mutation that prevents glucose uptake in E. coli (Deutscher et al.,
2006) was introduced from the GI698 DPTS strain into OP50 bacteria using
a standard phage-transduction method (Sambrook et al., 1989). The double
mutant was selected by picking colonies on kanamycin-containing LB plates
and confirmed by the formation of white colonies on McConkey agar medium
plates containing 0.5% glucose (Figure S3).
Quantitative RT-PCR
RNA extraction, purification, and reverse transcription were performed as
described (Taubert et al., 2006). Quantitative RT-PCR was carried out in
a 7300 Real-Time PCR System (Applied Biosystems; Foster City, CA) and
analyzed using the Ct method (Applied Biosystems Prism 7700 User Bulletin
#2, http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf). mRNA
levels of act-1, nhr-23, and/or ama-1were used for normalization as indicated.
The average of at least two technical repeats was used for each biological data
point. Primer sequences are available on request.
Measurement of Glucose and Glycerol
Glycerol levels were quantified as described (Lamitina et al., 2004) using Free
Glycerol Reagent (Sigma). Glucose levels were determined essentially as
described (Lamitina and Strange, 2005), with modifications. Briefly, neutral-
ized perchloric acid worm extracts prepared as described (Lamitina et al.,
2004) were used for quantification of glucose concentration using Amplex
Red Glucose/Glucose Oxidase Kit (Molecular Probes; Carlsbad, CA). Protein
content was measured with BCA Assay Kit (Pierce; Rockford, IL) and used
for the normalization of glucose and glycerol levels. Approximately 10,000
synchronized day 1 adult worms were used for one data set.etabolism 10, 379–391, November 4, 2009 ª2009 Elsevier Inc. 389
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Oxygen consumption rates were determined using the Oxytherm (Hansatech;
Norfolk, UK), which is a DW1/AD Clark-type oxygen electrode, as described
(Schulz et al., 2007). Approximately 5000 synchronized day 1 adult worms
were collected, quickly washed three times in M9 buffer, resuspended in
1 ml of M9, and transferred into the chamber. Respiration was measured at
20C, and the oxygen consumption rates were automatically calculated by
using the ‘‘Rate Cursors’’ function in the Oxygraph program (Hansatech).
Fluorescence Microscopy
All pictures of transgenic animals were captured using a Retiga EXi Fast 1394
CCD digital camera (QImaging; Burnaby, BC, Canada) attached to a Zeiss Ax-
ioplan 2 compound microscope (Zeiss Corporation; Jena, Germany). The
expression of sod-3::GFP was assayed as described previously (Libina
et al., 2003). Briefly, well-fed 3-day-old adult animals grown at 20C were
mounted on 2% agarose slides (10 per slide). The level of sod-3::GFP in
the head muscle was scored blindly. P values were calculated using the c2
test as described (Tullet et al., 2008). The expression level of ins-7::GFP was
examined as described previously (Murphy et al., 2007). Subcellular localiza-
tion of DAF-16::GFP was determined as previously described (Lin et al., 2001).
ACCESSION NUMBERS
The accession number for the microarray data is GSE18563 (NCBI-GEO).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental References, six tables, and 19
figures and can be found online at http://www.cell.com/cell-metabolism/
supplemental/S1550-4131(09)00302-7.
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